Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Asynchronous evolution of epithelium and stroma differentiates precursor lesions from pancreatic cancer.

Cancer discovery·2026
Same author

Personalized machine learning-guided radiation dose escalation in newly diagnosed glioblastoma: prospective pilot study.

Nature communications·2026
Same author

Brain tumor segmentation in Sub-Saharan Africa patient population: The BraTS-Africa challenge.

Neuro-oncology advances·2026
Same author

MRI and Clinical Features of Nonenhancing <i>IDH</i>-Wild-Type Glioblastomas: How to Make an Early Diagnosis and Distinguish from Mimics.

AJNR. American journal of neuroradiology·2026
Same author

Multi-Institutional Annotated Multiparametric MRI Dataset of Pediatric High-Grade Gliomas.

Radiology. Artificial intelligence·2026
Same author

Automatic longitudinal assessment of brain metastases improves detection of disease progression.

Neuro-oncology advances·2026

Related Experiment Video

Updated: Oct 13, 2025

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
05:45

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

9.8K

Quantifying T2-FLAIR Mismatch Using Geographically Weighted Regression and Predicting Molecular Status in Lower-Grade

S Mohammed1,2, V Ravikumar2, E Warner2

  • 1From the Departments of Biostatistics (S.M., A.R.) ukarvind@umich.edu.

AJNR. American Journal of Neuroradiology
|November 12, 2021
PubMed
Summary
This summary is machine-generated.

Quantifying the T2-FLAIR mismatch sign using geographically weighted regression accurately predicts isocitrate dehydrogenase (IDH)-mutant 1p/19q noncodeleted gliomas. This novel approach offers high predictive power for molecular status in lower-grade gliomas.

More Related Videos

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
09:17

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

2.4K
Advancements in the Metabolic Profiling of Three-Dimensional Brain Tumor Spheroids for Drug Screening
06:50

Advancements in the Metabolic Profiling of Three-Dimensional Brain Tumor Spheroids for Drug Screening

Published on: September 5, 2025

60

Related Experiment Videos

Last Updated: Oct 13, 2025

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
05:45

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

9.8K
Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
09:17

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

2.4K
Advancements in the Metabolic Profiling of Three-Dimensional Brain Tumor Spheroids for Drug Screening
06:50

Advancements in the Metabolic Profiling of Three-Dimensional Brain Tumor Spheroids for Drug Screening

Published on: September 5, 2025

60

Area of Science:

  • Neuro-oncology
  • Medical Imaging Analysis
  • Computational Pathology

Background:

  • The T2-FLAIR mismatch sign is a validated imaging biomarker for isocitrate dehydrogenase (IDH)-mutant 1p/19q noncodeleted gliomas.
  • Radiologists visually identify this sign on preoperative MRI scans, demonstrating high positive predictive value.

Purpose of the Study:

  • To develop and validate a quantitative approach for the T2-FLAIR mismatch sign.
  • To utilize this quantification to predict the molecular status of lower-grade gliomas.

Main Methods:

  • Analysis of multiparametric MR imaging from 108 lower-grade glioma tumors.
  • Application of geographically weighted regression to estimate the T2-FLAIR mismatch sign objectively.
  • Construction and statistical analysis of residual signatures (probability density functions).

Main Results:

  • Statistically significant differences in residual signatures between IDH-mutant 1p/19q noncodeleted tumors and other glioma categories (P = .05).
  • A classifier achieved an area under the curve (AUC) of 0.98 for predicting molecular status, with high specificity and sensitivity.
  • The classifier also predicted the T2-FLAIR mismatch sign itself with an AUC of 0.93.

Conclusions:

  • Geographically weighted regression-based residual signatures are highly informative for the T2-FLAIR mismatch sign.
  • This quantitative method accurately identifies IDH-mutation and 1p/19q codeletion status.
  • Prospective multi-institutional validation is recommended to confirm the utility of this T2-FLAIR mismatch sign quantification.